Effects of proton pump inhibitor use on risk of Clostridium difficile infection: a hospital cohort study

被引：0
|
作者：
Yoon Hee Park
Jong Mi Seong
Soyeon Cho
Hye Won Han
Jae Youn Kim
Sook Hee An
Hye Sun Gwak
机构：
[1] Ewha Womans University,Division of Life and Pharmaceutical Sciences, College of Pharmacy
[2] Asan Medical Center,Department of Pharmacy
[3] Wonkwang University,College of Pharmacy
来源：
Journal of Gastroenterology | 2019年 / 54卷
关键词：
Proton pump inhibitor; C; Diarrhea;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1052 / 1060
页数：8
相关论文
共 50 条
  • [1] Effects of proton pump inhibitor use on risk of Clostridium difficile infection: a hospital cohort study
    Park, Yoon Hee
    Seong, Jong Mi
    Cho, Soyeon
    Han, Hye Won
    Kim, Jae Youn
    An, Sook Hee
    Gwak, Hye Sun
    JOURNAL OF GASTROENTEROLOGY, 2019, 54 (12) : 1052 - 1060
  • [2] Proton Pump Inhibitor Therapy and Risk of Clostridium difficile Infection (CDI): A Nationwide Cohort Study
    Trujillo, Sophie
    Desai, Aakash
    Dalal, Shaman
    Sandhu, Dalbir S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S112 - S112
  • [3] Proton Pump Inhibitor Use and the Risk of Clostridium difficile Infection by Route of Administration
    Stevens, Vanessa
    Brown, Jack E.
    Dumyati, Ghinwa
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S183 - S184
  • [4] Proton Pump Inhibitor Use Predicts Severity of Clostridium difficile Infection
    Haider, Fyeza
    Raza, Naeem
    Komar, MIchael
    Inverso, NIcholas
    Rahman, Omar
    Prall, Stacy
    Sartorius, Jennifer
    Esolen, Lisa
    Shepperson, Staci
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 : S409 - S410
  • [5] Assessing the Risk of Hospital-Acquired Clostridium Difficile Infection With Proton Pump Inhibitor Use: A Meta-Analysis
    Arriola, Vanessa
    Tischendorf, Jessica
    Musuuza, Jackson
    Barker, Anna
    Rozelle, Jeffrey W.
    Safdar, Nasia
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2016, 37 (12): : 1408 - 1417
  • [6] Proton-Pump Inhibitor Use and the Risk of Community-Associated Clostridium difficile Infection
    Inghammar, Malin
    Svanstrom, Henrik
    Voldstedlund, Marianne
    Melbye, Mads
    Hviid, Anders
    Molbak, Kare
    Pasternak, Bjorn
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (12) : E1084 - E1089
  • [7] Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure
    Stevens, Vanessa
    Dumyati, Ghinwa
    Brown, Jack
    van Wijngaarden, Edwin
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (10) : 1035 - 1042
  • [8] Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection
    Barletta, Jeffrey F.
    El-Ibiary, Shareen Y.
    Davis, Lindsay E.
    Bao Nguyen
    Raney, Carrington R.
    MAYO CLINIC PROCEEDINGS, 2013, 88 (10) : 1085 - 1090
  • [9] Are Proton Pump Inhibitors a True Risk Factor in Clostridium difficile Infection? A Longitudinal Cohort Study
    Hong, Kyoung Sup
    Kang, Seung Joo
    Im, Jong Pil
    Kim, Jon Sung
    GASTROENTEROLOGY, 2011, 140 (05) : S79 - S79
  • [10] Proton Pump Inhibitors and the Risk for Clostridium difficile Infection
    Famularo, Giuseppe
    Gasbarrone, Laura
    De Simone, Claudio
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (01): : 31 - 32
12345